期刊文献+

Graves病局部免疫调节治疗对免疫学指标的影响 被引量:2

下载PDF
导出
摘要 目的:观察Graves病(GD)局部免疫调节治疗对免疫学指标的影响。方法:将120例Graves病患者随机分成对照组和治疗组,每组60例,对照组予以口服丙硫氧嘧啶,疗程2年;治疗组在对照组基础上予以B超引导下甲状腺局部注射地塞米松5 mg及生长抑素类似物0.1 mg,每2周1次,共6次。所有患者均行低碘饮食。观察两组血清甲状腺激素水平、免疫学指标变化及总疗程结束随访1年后甲亢复发率。结果:两组均能有效恢复甲状腺激素水平;治疗组TGAb(抗甲状腺球蛋白抗体)、TMAb(抗甲状腺微粒体抗体)、IgG、Ig M含量较对照组显著减低(P<0.05);治疗组TRAb(促甲状腺激素受体抗体)转阴率86%,对照组转阴率59%(P<0.01)。结论:甲状腺局部注射地塞米松和生长抑素免疫调节治疗,可有效改善Graves病免疫学指标,提高Graves病的缓解率,降低复发率。
出处 《实用临床医学(江西)》 CAS 2007年第12期30-32,共3页 Practical Clinical Medicine
基金 江西省卫生厅科研基金资助项目(041054)
  • 相关文献

参考文献15

二级参考文献61

  • 1陈灏珠.实用内科学,第10版[M].北京:人民卫生出版社,1998.2115.
  • 2顾明君 刘志民 等.地塞米松甲状腺注射治疗重度甲状腺功能亢进[J].药学实践,1994,7:42-43.
  • 3花天放.来自甲状腺上动脉的甲状旁腺血供[J].国外医学:创伤与外科基本问题分册,1995,16(2):116-116.
  • 4白耀 戴为信 等.长期药物治疗甲亢患者血清甲状腺刺激免疫球蛋白的变化[J].中华内分泌代谢杂志,1987,3(3):137-137.
  • 5Galkin EV. First clinical experience of radio - endovascular functional thyroidectomy in the treatment of diffuse toxic goiter [ J ]. Vestn Rentgenol Radiol ( Russian ),1994, (3) : 29- 35.
  • 6[1]Weetman AP, McGregor AM. Autoimmune thyroid disease: further development in our understanding[M] .Endocr Rev, 1994,15:788.
  • 7[2]Cooper DS:Antithyroid drugs for treatment of hyperthyroidism cause by Graves disease. Endocrinology and Metabolism[ M ]. Clinics of North America, 1998,27: 225.
  • 8[3]Braverman LE.Contemporary Endoerinology:Dieases of the Thyroid[M].Human Press, 1997.125.
  • 9Pimentel Muinos FX, Munoz-Fernandez MA, Fresno M,et al. Control of T Lymphocyte Activationand IL-2 Receptor Expression by Endogenously Secreted Lymphokines[J]. J Immunol, 1994,152 :5 714-5 722.
  • 10Bertalena L, Grasso L, Bregioni, et al. Serum Interleukin-6 in Amiodarone-induced Thyrotoxicosis[J]. J Clin Endocrinol Metab, 1994,78 (2) : 423-427

共引文献109

同被引文献18

  • 1刘超.Graves眼病的诊断和治疗[J].临床内科杂志,2004,21(6):363-367. 被引量:6
  • 2孙治华,姚斌,翁建平.Graves眼病的诊治新进展[J].国外医学(内科学分册),2005,32(1):21-25. 被引量:22
  • 3蒋琳,刘超.甲状腺疾病局部免疫调节治疗的研究进展[J].中国实用内科杂志,2005,25(9):851-853. 被引量:38
  • 4陈灏珠.实用内科学[M].11版.北京:人民卫生出版社,2004.1857-1859.
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2007:712-717.
  • 6Bennedbaek F N,Karstrup S, Hegedus L. Percutaneous Ethanol Injection Therapy in the Treatment of Thyroid and Parathyroid Diseases[J]. Eur J Endocrinol, 1997,136(3) :240-250.
  • 7Marti U, Ruchti C, Kampf J, et al. Nuclear Localization of Epidermal Growth Factor And Epidermal Growth Factor Receptors in Human Thyroid Tissues[J]. Thyroid, 2001,11 : 137- 145.
  • 8Eckstein A K, Lax H, Lsch C, et al. Patients with severe Graves'ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission [J]. Clin Endocrinol(Oxf),2007, 67(4): 607-612.
  • 9Marino M, Morabito E, Brunetto M R, et al. Acute and severe liver damage associated with intravenous gluco- corticoid pulse therapy in patients with Graves'ophthal- mopathy [J ]. Thyroid, 2004, 14(5):403--406.
  • 10Cidlowski J A,King K L,Evans Storms R B,et al.The bi- ochemistry and molecular biology of glucocorticoid-in- duced apoptosis in the immune system[J]. Recent Prog Horm Res, 1996,51: 457-490.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部